SemperFITrader

@BearGrylls @MiracleSeries Faith of a 9 year old to be healed from cancer and healing it was, incredible. Jesus still heals today as he did in Biblical days, Faith is real, prayer is real. This story is just one of many you see on the new Miracles series on the Angel Network. As Natalie Grant was singing live with her social media platform during COVID she responded to a comment made with a song she would sing called "Miracles", she asked all who watching too pray, the boy being prayed for got a huge pray chain and was healed during the song and instantly. You literally see what looks like a Angel ORB in the video. This was LIVE for all to see. Also, recommend a great read by Lee Storbel, numerous documented miracles there. Here is a link to watch this episod Free on Facebook. #JesusHeals #Miracles fb.watch/DtImORI3pf/

$NWBO More Dockets today, trying to keep up LOL."Citadel Securities LLC (“Citadel”), in particular, has relentlessly advanced frivolous discovery requests as a litigation tactic. For example, NWBO has spent months and expended endless resources negotiating Citadel’s wholly improper subpoena on its non-testifying expert and attorney, ultimately requiring NWBO to move for a protective order. See ECF 265. Moreover, after the Court denied Defendants’ second motion to compel additional baiting order calculations, ECF 255, Citadel took immediate steps to circumvent that order. Despite the Court’s ruling, Citadel sent a 228-page document seeking “verification” of every baiting order calculation"

$NWBO New Docket...

$NWBO Citadel Attorney withdraws.

Final Docket pages..............

$NWBO Follow up dockets from NWBO to Judge Stein. Continuation of all pages will be in the reply of posts. Post # 1

Post # 3

Post # 2

@joeretired41 no problem

@SouthernDrive21 Thanks for the update SFT!

$NWBO New Docket On July 29, 2026, NWBO's counsel at Kasowitz LLP sent a letter to Magistrate Judge Gary Stein requesting permission to file its Response to Defendants' Motion for Clarification or Reconsideration with limited redactions. NWBO explains that its response discusses: Information that Defendants themselves designated as "Highly Confidential" under the Protective Order in the case. Exhibits that the Defendants have already asked the Court to seal in earlier docket entries (Dkts. 298, 299-1, and 299-2). NWBO asks the Court to: Allow the public version of its response to contain narrowly tailored redactions. Permit the complete, unredacted version to be filed under seal.

@joeretired41 Agree completely

$NWBO 57 and Gary/skitahoe that loan shares out may benefit themselves in the shortrun but in the long-term they hurt the collective shareholder group and the company as they assist the MM/HFs in keeping the price suppressed! These types of investors are self serving clowns.

@MapleStax RTY

Trade $ES instead of $NQ You’ll thank me later

@d_stock07734 @KennethPar49290 Either way d_stock, its all positive, the possibilities at least are there.

$NWBO The Baker Brothers - or under its official name “Baker Bros. Advisors LP”, is by far the biggest “Healthcare only” investment firm in the BioTech and Pharma ecosystem - managing $28.1B of Assets Under Management (AUM) 🧵📷. Just for comparison - the second biggest investment firm - orbimed - is far behind with “only” $20.6B of assets under its management. The story of the “Baker Brothers” is a story of both patience and persistence that played a huge rule in their biggest investment ever - Seagen (formally known as Seattle Genetics). Julian and Felix Baker began investing in Seagen in 2003 when they made their initial investment while the company had no drugs on the market and was barely breaking even. In order to strengthen the company’s leadership Felix Baker joined Seagen's board of directors and played a leading role in its long-term strategy. Up until 2023 the investment firm maintained its high conviction and substantial stake and took part in the company’s strategic plans and operations. In March of 2023 announced an all-cash acquisition of Seagen for $43 billion or $229 per share - one of the biggest M&A deals ever made in the BioTech and Pharma ecosystem. In December of that year the deal was officially closed and the Baker Brothers received $10 billion in cash for their stake in the company. This was and still is one of the largest single Return on Investment (ROI) in BioTech history. Now check out a Posting on the famous IFLUB

CHGGPT response: Yorkville: Yorkville’s NWBO conversions NWBO’s 2025 Form 10-K states: The original $5 million December 2024 Yorkville note was fully converted during 2025. NWBO issued Yorkville approximately 21.5 million common shares for that conversion. Yorkville’s June 2025 note totaled $3 million. By December 31, 2025, Yorkville had converted $2.8 million of that note into approximately 12.5 million shares. Therefore, during 2025, NWBO issued Yorkville approximately: 21.5 million + 12.5 million = 34 million NWBO shares public records cannot establish how many it still owns. Its position appears more consistent with structured financing and periodic conversion/resale than a disclosed long-term strategic investment. Yorkville is also generally prevented from converting enough debt to beneficially own more than 4.99% of NWBO’s outstanding shares, unless it gives at least 65 days’ notice to waive the limitation. The agreement specifically says Yorkville is generally not obligated to report its current holdings to NWBO when requesting conversions Baker Brothers: No evidence in the latest available SEC filings that it owns NWBO.

@KennethPar49290 Yea believe your right, my hope is Dr. Jenkins can be a bridge for Baker Brothers to invest in NWBO, if that would happen then it could blow the doors off the entire investment community for us investors.

@SouthernDrive21 I don’t believe that BB own any shares of NWBO

The Baker Brothers - or under its official name “Baker Bros. Advisors LP”, is by far the biggest “Healthcare only” investment firm in the BioTech and Pharma ecosystem - managing $28.1B of Assets Under Management (AUM) 🧵📷. Just for comparison - the second biggest investment firm - orbimed - is far behind with “only” $20.6B of assets under its management. The story of the “Baker Brothers” is a story of both patience and persistence that played a huge rule in their biggest investment ever - Seagen (formally known as Seattle Genetics). Julian and Felix Baker began investing in Seagen in 2003 when they made their initial investment while the company had no drugs on the market and was barely breaking even. In order to strengthen the company’s leadership Felix Baker joined Seagen's board of directors and played a leading role in its long-term strategy. Up until 2023 the investment firm maintained its high conviction and substantial stake and took part in the company’s strategic plans and operations. In March of 2023 announced an all-cash acquisition of Seagen for $43 billion or $229 per share - one of the biggest M&A deals ever made in the BioTech and Pharma ecosystem. In December of that year the deal was officially closed and the Baker Brothers received $10 billion in cash for their stake in the company. This was and still is one of the largest single Return on Investment (ROI) in BioTech history.

$nwbo @alphavestcap Homework.Investwell Tuesday, July 28, 2026 2:51:58 PM Since Dr. Jenkins has joined Northwest as Strategic Advisor I've thought this would be the keystone after approval for NWBO. Her ties to the Baker Brothers cannot be underestimated IMO... Dr. Annalisa Jenkins, M.B.B.S., F.R.C.P., intersects with Baker Brothers Advisors LP (a prominent biotech-focused hedge fund) primarily through her board representation and governance roles at portfolio companies where Baker Brothers holds major equity stakes. Rather than being a direct employee of the hedge fund, her involvement is structured around corporate governance and leadership at mutual life sciences firms. Key Touchpoints and Intersections Skye Bioscience, Inc.: Dr. Jenkins served as a member of the Board of Directors for Skye Bioscience. Concurrently, Baker Brothers Advisors LP is a major institutional shareholder in the company, holding significant portions of common stock and pre-funded warrants via its funds, such as Baker Brothers Life Sciences, L.P. and 667, L.P.. Dimension Therapeutics: Dr. Jenkins previously served as the President and Chief Executive Officer of Dimension Therapeutics, a gene therapy company she successfully took public on the NASDAQ and later sold to Ultragenyx. Securities filings from her tenure reflect routine legal and financial cross-coordination involving her as CEO and Baker Brothers as a core institutional investor and management entity. Shared Life Sciences Ecosystem: Because Baker Brothers is one of the world's premier investment firms targeted at clinical-stage biopharmaceuticals, Dr. Jenkins' multi-decade career as an R&D executive and independent board chair frequently aligns with companies backing or backed by the hedge fund's capital.

$NWBO Uncovered new document today that is now available, remaining 100 plus pages are all the communication, exhibits etc. But here is the main one, some lines even redacted. Defendants are asking the judge to reconsider the July 10 order. The filing is a request for a pre-motion conference so they can ask Judge Stein to clarify or reconsider one paragraph of the July 10 discovery order. Specifically, they object to the statement: "If the algorithms were used to conduct the trading in NWBO stock at issue, then evidence about them is plainly relevant and proportional to this case."

$NWB0 ..... "for entertainment purposes only" 😎